Kruijer P S, Klok R P, van den Koedijk C D, Blankenstein M A, Voskuil J H, Verzeijlbergen J F, Ensing G J, Herscheid J D
Radionuclide Centre, Free University, Amsterdam, The Netherlands.
Nucl Med Biol. 1997 Nov;24(8):719-22. doi: 10.1016/s0969-8051(97)00111-x.
A 123I-labeled tamoxifen derivative with a high affinity for the antiestrogen-binding site (AEBS) has been prepared. Biodistribution studies in rats showed a good linear correlation between the AEBS contents of tissue in fmol/g and the accumulated amount of radioactivity in percent dose per gram at 24 h.
已制备出一种对抗雌激素结合位点(AEBS)具有高亲和力的123I标记的他莫昔芬衍生物。在大鼠身上进行的生物分布研究表明,在24小时时,组织中以fmol/g为单位的AEBS含量与每克组织中以剂量百分比表示的放射性累积量之间存在良好的线性相关性。